This website is intended for healthcare professionals only.

Newsletter      
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

TAVI Resources

Summarising the evidence for improved patient outcomes and increased economic benefit with a TAVI procedure vs alternative pathways, taking into account organisational efficiency, budget considerations, patient choice and how to implement change in your organisation.

An introduction to aortic stenosis, the population health burden and the TAVI pathway

Although the condition can be asymptomatic for years, when symptoms do appear, untreated patients with severe AS have high mortality (up to 50% within 2 years).

TAVI is eligible for the all-risk severe symptomatic aortic stenosis patient population

After the first successful TAVI procedure in 2002, >300,000 TAVI procedures have since taken place, and numerous prospective trials and observational studies have reported improved survival of TAVI compared with SAVR.

Severe symptomatic aortic stenosis patients report improved outcomes with TAVI vs SAVR

Patient-related benefits and patients’ quality of life have been reported to be better following TAVI compared with SAVR for patients with ssAS.

Optimising organisational efficiencies in the treatment of patients with severe, symptomatic aortic stenosis

The TAVI approach is a driver for organisational benefits, including shorter waiting lists, cuts to procedural times, increase in hospital capacity and shorter length of hospital stay.

How does partnering with Industry benefit your organisation? Implementing TAVI best practices

The Edwards Benchmark Programme is an educational standardised care pathway with a programme designed to deliver good, reproducible patient outcomes and access, and improved institutional capacity driven by proven best practice.

This content is sponsored by Edwards Lifesciences